These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16234453)

  • 41. Primary posterior capsulorhexis with anterior vitrectomy in preventing posterior capsule opacification in pediatric cataract microsurgery.
    Luo Y; Lu Y; Lu G; Wang M
    Microsurgery; 2008; 28(2):113-6. PubMed ID: 18220313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraoperative enoxaparin minimizes inflammatory reaction after pediatric cataract surgery.
    Rumelt S; Stolovich C; Segal ZI; Rehany U
    Am J Ophthalmol; 2006 Mar; 141(3):433-7. PubMed ID: 16490487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of whether intracameral dexamethasone predisposes to glaucoma after pediatric cataract surgery.
    Mataftsi A; Dabbagh A; Moore W; Nischal KK
    J Cataract Refract Surg; 2012 Oct; 38(10):1719-23. PubMed ID: 22841425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is early surgery for congenital cataract a risk factor for glaucoma?
    Vishwanath M; Cheong-Leen R; Taylor D; Russell-Eggitt I; Rahi J
    Br J Ophthalmol; 2004 Jul; 88(7):905-10. PubMed ID: 15205235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term results of bilateral congenital cataract treated with early cataract surgery, aphakic glasses and secondary IOL implantation.
    Kim DH; Kim JH; Kim SJ; Yu YS
    Acta Ophthalmol; 2012 May; 90(3):231-6. PubMed ID: 20819081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anticoagulant and fibrinolytic therapies for anterior chamber fibrin following cataract surgery in the rabbit eye].
    Kimura M; Eguchi S; Araie M; Akahoshi T; Kohda F
    Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1240-7. PubMed ID: 1442347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of epilenticular IOL implantation vs technique of anterior and primary posterior capsulorhexis with anterior vitrectomy in paediatric cataract surgery.
    Rastogi A; Monga S; Khurana C; Anand K
    Eye (Lond); 2007 Nov; 21(11):1367-74. PubMed ID: 16763657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracameral tissue plasminogen activator: management of a fibrin clot occluding a Molteno tube.
    Pastor SA; Schumann SP; Starita RJ; Fellman RL
    Ophthalmic Surg; 1993 Dec; 24(12):853-4. PubMed ID: 8115104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
    Zwaan J; Latimer WB
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):476-83. PubMed ID: 9640569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in axial length growth after congenital cataract surgery and intraocular lens implantation in children younger than 5 years.
    Hussin HM; Markham R
    J Cataract Refract Surg; 2009 Jul; 35(7):1223-8. PubMed ID: 19545812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A retrospective comparison of techniques to prevent secondary cataract formation following posterior chamber intraocular lens implantation in infants and children.
    Koch DD; Kohnen T
    Trans Am Ophthalmol Soc; 1997; 95():351-60; discussion 361-5. PubMed ID: 9440179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report.
    Yoshino H; Seki M; Ueda J; Yoshino T; Fukuchi T; Abe H
    BMC Ophthalmol; 2012 Mar; 12():3. PubMed ID: 22433746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of 2 techniques of intraocular lens implantation in pediatric cataract surgery.
    Faramarzi A; Javadi MA
    J Cataract Refract Surg; 2009 Jun; 35(6):1040-5. PubMed ID: 19465290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-inflammatory effect of low-molecular-weight heparin in pediatric cataract surgery: a randomized clinical trial.
    Vasavada VA; Praveen MR; Shah SK; Trivedi RH; Vasavada AR
    Am J Ophthalmol; 2012 Aug; 154(2):252-258.e4. PubMed ID: 22541652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Morphology of secondary cataract membrane in child post congenital cataract surgery--case report].
    Kanigowska K; Grajkowska W; Grałek M; Pronicki M
    Klin Oczna; 2007; 109(10-12):461-3. PubMed ID: 18488397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cataract surgery in children with and without retinopathy of prematurity.
    Yu YS; Kim SJ; Chang BL
    J Cataract Refract Surg; 2004 Jan; 30(1):89-94. PubMed ID: 14967273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of postcataract fibrinous membranes with tissue plasminogen activator.
    Moon J; Chung S; Myong Y; Chung S; Park C; Baek N; Rhee S
    Ophthalmology; 1992 Aug; 99(8):1256-9. PubMed ID: 1513579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibrin reaction after uveitic cataract surgery: treatment and prevention.
    da Rocha Lima B; Pichi F; Nucci P; Srivastava SK; Lowder CY
    Eur J Ophthalmol; 2014; 24(4):626-8. PubMed ID: 24519510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of anterior segment fibrinous reactions and hemorrhage with intracameral low dose rt-PA: clinical study and review of the literature].
    Le Rouic JF; Behar-Cohen F; Nghiem MH; Renard G; Chauvaud D
    J Fr Ophtalmol; 2000 Dec; 23(10):977-83. PubMed ID: 11139689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes.
    Starck T; Hopp L; Held KS; Marouf LM; Yee RW
    J Cataract Refract Surg; 1995 Mar; 21(2):219-24. PubMed ID: 7791066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.